Sulfenamido-sulfonamides as inhibitors of carbonic anhydrase isozymes I, II and IV.

Reaction of 2-nitrophenyl- and 4-nitrophenylsulfenyl-chlorides with aromatic/heterocyclic sulfonamides containing a free amino group afforded sulfenamido-sulfonamides, which were inhibitors of the zinc enzyme carbonic anhydrase (CA). Oxidation of these derivatives with potassium permanganate in acetone led to the corresponding bis-sulfonamides. Good inhibition of three CA isozymes (CA I, II and IV, respectively) was observed with some of the new compounds, the bis-sulfonamides being more active than the sulfenamido-sulfonamides. A possible in vivo transformation of the last type of compounds, leading to an omeprazole-like gastric acid secretion inhibitor is also discussed.

[1]  D. Hewett‐Emmett,et al.  Functional diversity, conservation, and convergence in the evolution of the alpha-, beta-, and gamma-carbonic anhydrase gene families. , 1996, Molecular phylogenetics and evolution.

[2]  A. Brändström,et al.  The mechanism for inhibition of gastric (H+ + K+)-ATPase by omeprazole. , 1985, Biochimica et biophysica acta.

[3]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes# , 1996 .

[4]  P. Lindberg,et al.  The mechanism of action of the gastric acid secretion inhibitor omeprazole. , 1986, Journal of medicinal chemistry.

[5]  T. Steinmetzer,et al.  Design of Enzyme Inhibitors as Drugs , 1989 .

[6]  W. Sly,et al.  Carbonic anhydrase IV expression in rat and human gastrointestinal tract regional, cellular, and subcellular localization. , 1995, The Journal of clinical investigation.

[7]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 36. Inhibition of isozymes I and II with Schiff bases derived from chalkones and aromatic/heterocyclic sulfonamides , 1996 .

[8]  T. Maren,et al.  The Development of Topical Carbonic Anhydrase Inhibitors , 1995, Journal of glaucoma.

[9]  S. Patai.  The Chemistry of sulphenic acids and their derivatives , 1990 .

[10]  T. Maren,et al.  Carbonic anhydrase inhibitors: Synthesis and inhibitory properties of 1,3,4-thiadiazole-2,5-bissulfonamide , 1996 .

[11]  T. Yamada,et al.  Acid secretagogue-induced stimulation of gastric parietal cell gene expression. , 1989, The Journal of biological chemistry.

[12]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 24. A quantitative structure-activity relationship study of positively charged sulfonamide inhibitors , 1995 .

[13]  W. Im,et al.  Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups. , 1985, The Journal of biological chemistry.

[14]  G. Glaser,et al.  Antiepileptic drugs : mechanisms of action , 1980 .

[15]  D. Loo,et al.  Gastric acid secretion: activation and inhibition. , 1994, The Yale journal of biology and medicine.

[16]  B. Jonsson,et al.  Structural and functional differences between carbonic anhydrase isoenzymes I and II as studied by site-directed mutagenesis. , 1991, European journal of biochemistry.

[17]  G. Sachs,et al.  Membrane topology and omeprazole labeling of the gastric H+,K(+)-adenosinetriphosphatase. , 1993, Biochemistry.

[18]  R. Sykes,et al.  O-Sulfated .beta.-lactam hydroxamic acids (monosulfactams). Novel monocyclic .beta.-lactam antibiotics of synthetic origin , 1982 .

[19]  K. Väänänen,et al.  Proton channel part of vacuolar H+‐ATPase and carbonic anhydrase II expression is stimulated in resorbing osteoclasts , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  G. Sachs,et al.  The site of action of pantoprazole in the gastric H+/K(+)-ATPase. , 1993, Biochimica et biophysica acta.

[21]  G. W. Anderson,et al.  1,3,4-Thiadiazole- and Thiadiazolinesulfonamides as Carbonic Anhydrase Inhibitors. Synthesis and Structural Studies , 1956 .

[22]  G. Whitesides,et al.  Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants. , 1995, Journal of medicinal chemistry.

[23]  G. Sachs,et al.  The pharmacology of the gastric acid pump: the H+,K+ ATPase. , 1995, Annual review of pharmacology and toxicology.

[24]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes* , 1996 .

[25]  A. Shulkes,et al.  Achlorhydria induced changes in gastrin, somatostatin, H+/K+-ATPase and carbonic anhydrase in the sheep , 1992, Regulatory Peptides.

[26]  A. Balaban,et al.  Carbonic anhydrase inhibitors. V: Pyrylium salts in the synthesis of isozyme-specific inhibitors. , 1992, Journal of pharmaceutical sciences.

[27]  A. Osterman,et al.  Production of active human carbonic anhydrase II in E. coli. , 1988, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry.